Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2017 | Pages:
112 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
This report studies Bio-pharma in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering • Pfizer • F. Hoffmann-La Roche AG • Johnson & Johnson Services • Sanofi, Amgen • AbbVie • Merck & Co., Inc • Biogen Idec • Bayer AG • Eli Lilly and Company • Novartis AG GlaxoSmithKline Plc • Bristol-Myers Squibb Company • AstraZeneca PLC • Abbott Laboratories By types, the market can be split into • Monoclonal Antibodies • Recombinant Proteins • Granulocyte-Colony Stimulating Factor (G-CSF) • Interferons • Recombinant Human Insulin • Erythropoietin • Vaccines • Growth Hormones • Purified Proteins • Others By Application, the market can be split into • Metabolic Disorders • Oncology • Neurological Disorders • Cardiovascular Diseases • Inflammatory and Infectious Diseases • Others By Regions, this report covers (we can add the regions/countries as you want) • North America • China • Europe • Southeast Asia • Japan • India If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Bio-pharma Market Professional Survey Report 2017
1 Industry Overview of Bio-pharma
1.1 Definition and Specifications of Bio-pharma
1.1.1 Definition of Bio-pharma
1.1.2 Specifications of Bio-pharma
1.2 Classification of Bio-pharma
1.2.1 Monoclonal Antibodies
1.2.2 Recombinant Proteins
1.2.3 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.4 Interferons
1.2.5 Recombinant Human Insulin
1.2.6 Erythropoietin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Purified Proteins
1.2.10 Others
1.3 Applications of Bio-pharma
1.3.1 Metabolic Disorders
1.3.2 Oncology
1.3.3 Neurological Disorders
1.3.4 Cardiovascular Diseases
1.3.5 Inflammatory and Infectious Diseases
1.3.6 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Bio-pharma
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bio-pharma
2.3 Manufacturing Process Analysis of Bio-pharma
2.4 Industry Chain Structure of Bio-pharma
3 Technical Data and Manufacturing Plants Analysis of Bio-pharma
3.1 Capacity and Commercial Production Date of Global Bio-pharma Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Bio-pharma Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Bio-pharma Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Bio-pharma Major Manufacturers in 2016
4 Global Bio-pharma Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Bio-pharma Capacity and Growth Rate Analysis
4.2.2 2016 Bio-pharma Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Bio-pharma Sales and Growth Rate Analysis
4.3.2 2016 Bio-pharma Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Bio-pharma Sales Price
4.4.2 2016 Bio-pharma Sales Price Analysis (Company Segment)
5 Bio-pharma Regional Market Analysis
5.1 North America Bio-pharma Market Analysis
5.1.1 North America Bio-pharma Market Overview
5.1.2 North America 2012-2017E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Bio-pharma Sales Price Analysis
5.1.4 North America 2016 Bio-pharma Market Share Analysis
5.2 China Bio-pharma Market Analysis
5.2.1 China Bio-pharma Market Overview
5.2.2 China 2012-2017E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Bio-pharma Sales Price Analysis
5.2.4 China 2016 Bio-pharma Market Share Analysis
5.3 Europe Bio-pharma Market Analysis
5.3.1 Europe Bio-pharma Market Overview
5.3.2 Europe 2012-2017E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Bio-pharma Sales Price Analysis
5.3.4 Europe 2016 Bio-pharma Market Share Analysis
5.4 Southeast Asia Bio-pharma Market Analysis
5.4.1 Southeast Asia Bio-pharma Market Overview
5.4.2 Southeast Asia 2012-2017E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Bio-pharma Sales Price Analysis
5.4.4 Southeast Asia 2016 Bio-pharma Market Share Analysis
5.5 Japan Bio-pharma Market Analysis
5.5.1 Japan Bio-pharma Market Overview
5.5.2 Japan 2012-2017E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Bio-pharma Sales Price Analysis
5.5.4 Japan 2016 Bio-pharma Market Share Analysis
5.6 India Bio-pharma Market Analysis
5.6.1 India Bio-pharma Market Overview
5.6.2 India 2012-2017E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Bio-pharma Sales Price Analysis
5.6.4 India 2016 Bio-pharma Market Share Analysis
6 Global 2012-2017E Bio-pharma Segment Market Analysis (by Type)
6.1 Global 2012-2017E Bio-pharma Sales by Type
6.2 Different Types of Bio-pharma Product Interview Price Analysis
6.3 Different Types of Bio-pharma Product Driving Factors Analysis
6.3.1 Monoclonal Antibodies of Bio-pharma Growth Driving Factor Analysis
6.3.2 Recombinant Proteins of Bio-pharma Growth Driving Factor Analysis
6.3.3 Granulocyte-Colony Stimulating Factor (G-CSF) of Bio-pharma Growth Driving Factor Analysis
6.3.4 Interferons of Bio-pharma Growth Driving Factor Analysis
6.3.5 Recombinant Human Insulin of Bio-pharma Growth Driving Factor Analysis
6.3.6 Erythropoietin of Bio-pharma Growth Driving Factor Analysis
6.3.7 Vaccines of Bio-pharma Growth Driving Factor Analysis
6.3.8 Growth Hormones of Bio-pharma Growth Driving Factor Analysis
6.3.9 Purified Proteins of Bio-pharma Growth Driving Factor Analysis
6.3.10 Others of Bio-pharma Growth Driving Factor Analysis
7 Global 2012-2017E Bio-pharma Segment Market Analysis (by Application)
7.1 Global 2012-2017E Bio-pharma Consumption by Application
7.2 Different Application of Bio-pharma Product Interview Price Analysis
7.3 Different Application of Bio-pharma Product Driving Factors Analysis
7.3.1 Metabolic Disorders of Bio-pharma Growth Driving Factor Analysis
7.3.2 Oncology of Bio-pharma Growth Driving Factor Analysis
7.3.3 Neurological Disorders of Bio-pharma Growth Driving Factor Analysis
7.3.4 Cardiovascular Diseases of Bio-pharma Growth Driving Factor Analysis
7.3.5 Inflammatory and Infectious Diseases of Bio-pharma Growth Driving Factor Analysis
7.3.6 Others of Bio-pharma Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Bio-pharma
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Pfizer 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2016 Bio-pharma Business Region Distribution Analysis
8.2 F. Hoffmann-La Roche AG
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 F. Hoffmann-La Roche AG 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 F. Hoffmann-La Roche AG 2016 Bio-pharma Business Region Distribution Analysis
8.3 Johnson & Johnson Services
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Johnson & Johnson Services 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Johnson & Johnson Services 2016 Bio-pharma Business Region Distribution Analysis
8.4 Sanofi, Amgen
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Sanofi, Amgen 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Sanofi, Amgen 2016 Bio-pharma Business Region Distribution Analysis
8.5 AbbVie
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 AbbVie 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 AbbVie 2016 Bio-pharma Business Region Distribution Analysis
8.6 Merck & Co., Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Merck & Co., Inc 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Merck & Co., Inc 2016 Bio-pharma Business Region Distribution Analysis
8.7 Biogen Idec
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Biogen Idec 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Biogen Idec 2016 Bio-pharma Business Region Distribution Analysis
8.8 Bayer AG
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Bayer AG 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bayer AG 2016 Bio-pharma Business Region Distribution Analysis
8.9 Eli Lilly and Company
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Eli Lilly and Company 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Eli Lilly and Company 2016 Bio-pharma Business Region Distribution Analysis
8.10 Novartis AG GlaxoSmithKline Plc
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Novartis AG GlaxoSmithKline Plc 2016 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Novartis AG GlaxoSmithKline Plc 2016 Bio-pharma Business Region Distribution Analysis
8.11 Bristol-Myers Squibb Company
8.12 AstraZeneca PLC
8.13 Abbott Laboratories
9 Development Trend of Analysis of Bio-pharma Market
9.1 Global Bio-pharma Market Trend Analysis
9.1.1 Global 2017-2022 Bio-pharma Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Bio-pharma Sales Price Forecast
9.2 Bio-pharma Regional Market Trend
9.2.1 North America 2017-2022 Bio-pharma Consumption Forecast
9.2.2 China 2017-2022 Bio-pharma Consumption Forecast
9.2.3 Europe 2017-2022 Bio-pharma Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Bio-pharma Consumption Forecast
9.2.5 Japan 2017-2022 Bio-pharma Consumption Forecast
9.2.6 India 2017-2022 Bio-pharma Consumption Forecast
9.3 Bio-pharma Market Trend (Product Type)
9.4 Bio-pharma Market Trend (Application)
10 Bio-pharma Marketing Type Analysis
10.1 Bio-pharma Regional Marketing Type Analysis
10.2 Bio-pharma International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Bio-pharma by Region
10.4 Bio-pharma Supply Chain Analysis
11 Consumers Analysis of Bio-pharma
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Bio-pharma Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Bio-pharma
Table Product Specifications of Bio-pharma
Table Classification of Bio-pharma
Figure Global Production Market Share of Bio-pharma by Type in 2016
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Recombinant Proteins Picture
Table Major Manufacturers of Recombinant Proteins
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Picture
Table Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure Interferons Picture
Table Major Manufacturers of Interferons
Figure Recombinant Human Insulin Picture
Table Major Manufacturers of Recombinant Human Insulin
Figure Erythropoietin Picture
Table Major Manufacturers of Erythropoietin
Figure Vaccines Picture
Table Major Manufacturers of Vaccines
Figure Growth Hormones Picture
Table Major Manufacturers of Growth Hormones
Figure Purified Proteins Picture
Table Major Manufacturers of Purified Proteins
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Bio-pharma
Figure Global Consumption Volume Market Share of Bio-pharma by Application in 2016
Figure Metabolic Disorders Examples
Table Major Consumers in Metabolic Disorders
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Neurological Disorders Examples
Table Major Consumers in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Major Consumers in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Major Consumers in Inflammatory and Infectious Diseases
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Bio-pharma by Regions
Figure North America Bio-pharma Market Size (Million USD) (2012-2022)
Figure China Bio-pharma Market Size (Million USD) (2012-2022)
Figure Europe Bio-pharma Market Size (Million USD) (2012-2022)
Figure Southeast Asia Bio-pharma Market Size (Million USD) (2012-2022)
Figure Japan Bio-pharma Market Size (Million USD) (2012-2022)
Figure India Bio-pharma Market Size (Million USD) (2012-2022)
Table Bio-pharma Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bio-pharma in 2016
Figure Manufacturing Process Analysis of Bio-pharma
Figure Industry Chain Structure of Bio-pharma
Table Capacity and Commercial Production Date of Global Bio-pharma Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Bio-pharma Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Bio-pharma Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Bio-pharma Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Bio-pharma 2012-2017
Figure Global 2012-2017E Bio-pharma Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Bio-pharma Market Size (Value) and Growth Rate
Table 2012-2017E Global Bio-pharma Capacity and Growth Rate
Table 2016 Global Bio-pharma Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Bio-pharma Sales (K Pcs) and Growth Rate
Table 2016 Global Bio-pharma Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Bio-pharma Sales Price (USD/Pcs)
Table 2016 Global Bio-pharma Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Bio-pharma 2012-2017E
Figure North America 2012-2017E Bio-pharma Sales Price (USD/Pcs)
Figure North America 2016 Bio-pharma Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Bio-pharma 2012-2017E
Figure China 2012-2017E Bio-pharma Sales Price (USD/Pcs)
Figure China 2016 Bio-pharma Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Bio-pharma 2012-2017E
Figure Europe 2012-2017E Bio-pharma Sales Price (USD/Pcs)
Figure Europe 2016 Bio-pharma Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Bio-pharma 2012-2017E
Figure Southeast Asia 2012-2017E Bio-pharma Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Bio-pharma Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Bio-pharma 2012-2017E
Figure Japan 2012-2017E Bio-pharma Sales Price (USD/Pcs)
Figure Japan 2016 Bio-pharma Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Bio-pharma 2012-2017E
Figure India 2012-2017E Bio-pharma Sales Price (USD/Pcs)
Figure India 2016 Bio-pharma Sales Market Share
Table Global 2012-2017E Bio-pharma Sales (K Pcs) by Type
Table Different Types Bio-pharma Product Interview Price
Table Global 2012-2017E Bio-pharma Sales (K Pcs) by Application
Table Different Application Bio-pharma Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Pfizer Bio-pharma Business Region Distribution
Table F. Hoffmann-La Roche AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 F. Hoffmann-La Roche AG Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 F. Hoffmann-La Roche AG Bio-pharma Business Region Distribution
Table Johnson & Johnson Services Information List
Table Product A Overview
Table Product B Overview
Table 2015 Johnson & Johnson Services Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson Services Bio-pharma Business Region Distribution
Table Sanofi, Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi, Amgen Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Sanofi, Amgen Bio-pharma Business Region Distribution
Table AbbVie Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbVie Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AbbVie Bio-pharma Business Region Distribution
Table Merck & Co., Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co., Inc Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck & Co., Inc Bio-pharma Business Region Distribution
Table Biogen Idec Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biogen Idec Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Biogen Idec Bio-pharma Business Region Distribution
Table Bayer AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer AG Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bayer AG Bio-pharma Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly and Company Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eli Lilly and Company Bio-pharma Business Region Distribution
Table Novartis AG GlaxoSmithKline Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis AG GlaxoSmithKline Plc Bio-pharma Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table AstraZeneca PLC Information List
Table Abbott Laboratories Information List
Figure Global 2017-2022 Bio-pharma Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Bio-pharma Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Bio-pharma Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Bio-pharma Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Bio-pharma Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Bio-pharma Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Bio-pharma Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Bio-pharma Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Bio-pharma Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Bio-pharma by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Bio-pharma by Application 2017-2022
Table Traders or Distributors with Contact Information of Bio-pharma by Region 
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
